跳转至内容
Merck
CN
所有图片(1)

文件

安全信息

T-011

Supelco

−-Δ9-四氢大麻酚-D3标准液 溶液

1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

登录查看公司和协议定价
所有图片(1)

About This Item

经验公式（希尔记法）:
C21H27O2D3
CAS号:
81586-39-2
分子量:
317.48
EC 号:
200-659-6
UNSPSC代码:
41116107
NACRES:
NA.24

等级

certified reference material

质量水平

300

形式

liquid

特点

Snap-N-Spike®/Snap-N-Shoot®

包装

ampule of 1 mL

制造商/商品名称

Cerilliant®

drug control

Narcotic Licence Schedule D (Switzerland); psicótropo (Spain); Decreto Lei 15/93: Tabela IIB (Portugal)

浓度

1.0 mg/mL in methanol

技术

gas chromatography (GC): suitable
liquid chromatography (LC): suitable

应用

cannabis testing
cannabis testing

格式

single component solution

储存温度

−20°C

InChI

1S/C21H30O2/c1-5-6-7-8-15-12-18(22)20-16-11-14(2)9-10-17(16)21(3,4)23-19(20)13-15/h11-13,16-17,22H,5-10H2,1-4H3/i1D3

InChI key

CYQFCXCEBYINGO-FIBGUPNXSA-N

正在寻找类似产品? 访问 产品对比指南

相关类别

一般描述

它是 Δ9-THC 的内标物，后者是大麻的主要活性成分和主要精神活性大麻素。

应用

该认证加标溶液®适合用作药物研究、临床毒理学和法医测试应用中 LC/MS 或 GC/MS 法定量测试尿液或其他基质中Δ9-THC 水平的内标物。

该认证标准物质（CRM）还可作如下用途：

  • 开发基于固相萃取（SPE）的自动样品制备方法，以使用液相色谱-质谱法（LC-MS）测定血清、唾液和尿液中 ∆9-四氢大麻酚（THC）及其三种主要代谢物
  • 比较分析基于超高效液相色谱-串联质谱法（UHPLC-MS/MS）和固相微萃取-气相色谱-质谱法（SPME-GC/MS）的两种方法，以测定小体积口服液样品中的大麻素
  • 作为内标物，通过高效液相色谱-串联质谱（HPLC-MS/MS）定量分析人尿液和血浆样品中的 11 种大麻素及其代谢物

特点和优势

  • 完全符合 ISO/IEC 17025 和 ISO 17034 认证
  • 附综合分析证书（CoA），包括稳定性、均匀性、浓度准确性、不确定性和可追溯性数据
  • 通过实时稳定性研究严格测试，以确保准确性和保质期
  • 使用合格的精密天平进行重量准备，以确保最小不确定性
  • 氩气环境下火焰密封，装入安瓿以便长期保存
  • 提供方便的 DEA 豁免格式，以提高实验室效率

法律信息

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
CERTIFIED SPIKING SOLUTION is a registered trademark of Cerilliant Corporation
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

相关产品

产品编号
说明
价格

C-115

Cannabinol-D3 solution, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

H-026

(±)-11-羟基-Δ9-四氢大麻酚标准液 溶液, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

H-027

(±)-11-羟基-Δ9-四氢大麻酚标准液 溶液, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

H-041

(±)-11-Hydroxy-Δ9-THC-D3 solution, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

T-003

−-Δ9-四氢大麻酚-D3标准液 溶液, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

T-004

(±)-11-nor-9-羧基-Δ9-四氢大麻酚-D3标准液 CRM 溶液, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

T-005

(−)-Δ9-四氢大麻酚标准液 溶液, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

T-006

(±)-Δ-四氢大麻酸标准液 溶液, 100 μg/mL in methanol, ampule of 1 mL, Cerilliant®

T-007

(±)-11-nor-9-Carboxy-Δ9-THC-D9 solution, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

T-008

(±)-11-nor-9-羧基-Δ9-四氢大麻酚-D3标准液 CRM 溶液, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

T-018

(−)-11-nor-9-羧基-Δ9-THC 溶液, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

T-019

(−)-11-nor-9-羧基-Δ9-THC 溶液, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

T-038

(+)-11-去甲-Δ9-THC-9-羧酸葡糖苷酸 溶液, 100 μg/mL in methanol, ampule of 1 mL, Cerilliant®

T-047

(±)-Δ9-四氢大麻酚标准液 溶液, 100 μg/mL in heptane, ampule of 1 mL, Cerilliant®

T-080

(±)-cis-11-Nor-9-carboxy-Δ9-THC-D3 glucuronide solution, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

C-150

Cannabichromenic Acid (CBCA) solution, 1.0 mg/mL in acetonitrile, certified reference material, ampule of 1 mL, Cerilliant®

C-153

大麻酚酸（CBNA） 溶液, 1.0 mg/mL in acetonitrile, certified reference material, ampule of 1 mL, Cerilliant®

T-111

四氢次大麻酚酸（THCVA） 溶液, 1.0 mg/mL in acetonitrile, certified reference material, ampule of 1 mL, Cerilliant®

C-171

大麻环酸(CBLA)标准液 溶液, 0.5 mg/mL in acetonitrile, certified reference material, ampule of 1 mL, Cerilliant®

C-217

Hemp Compliance Mix solution, certified reference material, ampule of 1 mL, Cerilliant®

C-219

Cannabinoid Mixture (Neutrals) - 8 Component solution, 500 μg/mL in methanol (each analyte), certified reference material, ampule of 1 mL, Cerilliant®

T-151

THC-O-Acetate solution, 1 mg/mL in methanol, certified reference material, ampule of 1 mL, Cerilliant®

C-220

Cannabinoid Mixture - 3 Component solution, 1 mg/mL in methanol ((each analyte)), certified reference material, ampule of 1 mL, Cerilliant®

C-218

Cannabinoid Mixture (Acids) - 6 Component solution, 500 μg/mL (1% DIPEA and 0.05% Ascorbic acid in Acetonitrile,each analyte), certified reference material, ampule of 1 mL, Cerilliant®

T-112

11-Nor-9-carboxy-delta9-THCV solution, 100 μg/mL in methanol, certified reference material, ampule of 1 mL, Cerilliant®

C-244

Cannabichromenic Acid (CBCA) solution, 1 mg/mL (1% DIPEA and 0.05% Ascorbic acid in Acetonitrile), certified reference material, ampule of 1 mL, Cerilliant®

C-264

大麻环酸(CBLA)标准液 溶液, 0.5 mg/mL (0.1% DIPEA, 0.05 Ascorbic Acid in Acetonitrile), certified reference material, ampule of 1 mL, Cerilliant®

H-166

11-Nor-9beta-hydroxyhexahydrocannabinol (11-Nor-9beta-HHC) solution, 1 mg/mL (Acetonitrile (Degas)), certified reference material, ampule of 1 mL, Cerilliant®

T-158

(-)-11-nor-9-Carboxy-Delta8-THC-D3 solution, 100 μg/mL (Degassed Methanol), certified reference material, ampule of 1 mL, Cerilliant®

T-182

THC-O-Acetate solution, 1 mg/mL in acetonitrile, certified reference material, ampule of 1 mL, Cerilliant®

T-114

(-)-delta9-THC-O-beta-D-glucuronide sodium salt solution, 100 μg/mL (Degassed Methanol, (as free carboxylate)), certified reference material, ampule of 1 mL, Cerilliant®

H-165

Hexahydrocannabinol (HHC) solution, 1 mg/mL in methanol, certified reference material, ampule of 1 mL, Cerilliant®

警示用语：

Danger

危险分类

Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1

靶器官

Eyes

WGK

WGK 1

闪点(°F)

closed cup

闪点(°C)

closed cup

法规信息

监管及禁止进口产品

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ （Lot或Batch）字后找到。

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Dirk W Lachenmeier et al.
F1000Research, 8, 1394-1394 (2019-08-08)
Cannabidiol (CBD)-containing products are widely marketed as over the counter products, mostly as food supplements. Adverse effects reported in anecdotal consumer reports or during clinical studies were first assumed to be due to hydrolytic conversion of CBD to psychotropic Δ
Michal P Dybowski et al.
Forensic toxicology, 36(2), 415-423 (2018-07-03)
Analysis of drugs and their metabolites in biofluids usually demands the application of sample preparation methods that allow for full isolation of analyzed substances from the matrix. The purpose of this study was to develop a method using the QuEChERS
Florentina Villanueva et al.
International journal of hygiene and environmental health, 218(6), 522-534 (2015-05-31)
Twenty nine organic air pollutants including carbonyl compounds, alkanes, aromatic hydrocarbons and terpenes were measured in the indoor environment of different houses together with the corresponding outdoor measurements in Puertollano, the most industrialized city in central Iberian Peninsula. VOCs were

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门